Metabolic vulnerability of cisplatin‐resistant cancers

Florine Obrist, Judith Michels, Sylvère Durand, +9

The EMBO Journal

OncologyMedicineMetabolic RemodelingCancer GeneticsPharmacology +4

Trial Watch:

Jonathan Pol, Norma Bloy, Florine Obrist, +9

OncoImmunology

Cancer ImmunosurveillanceOncological IndicationsOncolytic VirusesImmunologyOncolytic Virotherapy +8

Trial Watch

Fernando Aranda, Erika Vacchelli, Florine Obrist, +8

OncoImmunology

InflammationToll-like ReceptorsCancer ImmunosurveillanceExperimental TlrMedicine +11

Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention

Delphine Lissa, Laura Senovilla, Santiago Rello‐Varona, +12

Proceedings of the National Academy of Sciences

MCL-1 dependency of cisplatin-resistant cancer cells

Judith Michels, Florine Obrist, Ilio Vitale, +8

Biochemical Pharmacology

MedicineTumor SuppressorCancer BiologyCell BiologyCancer Research +2

Trial watch

Erika Vacchelli, Fernando Aranda, Florine Obrist, +6

OncoImmunology

Cancer ImmunosurveillanceImmunomodulatory CytokinesMedicineImmunologyTumor Immunity +12

Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer

Judith Michels, Julien Adam, Aïcha Goubar, +11

Annals of Oncology

Prognostic BiomarkersIntracellular PolyMedicinePathologyHigh Levels +7

Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR

Shaoyi Zhang, Gautier Stoll, José Manuel Bravo‐San Pedro, +8

Cell Death and Disease

Metabolic features of cancer cells impact immunosurveillance

Adrien Joseph, Pan Juncheng, Michele Mondini, +24

Journal for ImmunoTherapy of Cancer

Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer

Pan Juncheng, Adrien Joseph, Antoine Lafarge, +16

Journal for ImmunoTherapy of Cancer